DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation

Gord Guo Zhu1,2, Chuanyong Lu1, Ivana Petrovic3

  • 1Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

PubMed
Summary

Genomic analysis of craniofacial osteosarcomas (CFOS) reveals complex alterations and mutations in key tumor suppressor genes like TP53. Actionable gene amplifications were found in nearly half of the cases studied.